Candidate genes for hereditary colorectal cancer: Mutational screening and systematic review
- PMID: 32449991
- DOI: 10.1002/humu.24057
Candidate genes for hereditary colorectal cancer: Mutational screening and systematic review
Abstract
Genome-wide approaches applied for the identification of new hereditary colorectal cancer (CRC) genes, identified several potential causal genes, including RPS20, IL12RB1, LIMK2, POLE2, MRE11, POT1, FAN1, WIF1, HNRNPA0, SEMA4A, FOCAD, PTPN12, LRP6, POLQ, BLM, MCM9, and the epigenetic inactivation of PTPRJ. Here we attempted to validate the association between variants in these genes and nonpolyposis CRC by performing a mutational screening of the genes and PTPRJ promoter methylation analysis in 473 familial/early-onset CRC cases, a systematic review of the published cases, and assessment of allele frequencies in control population. In the studied cohort, 24 (5%) carriers of (predicted) deleterious variants in the studied genes and no constitutional PTPRJ epimutations were identified. Assessment of allele frequencies in controls compared with familial/early-onset patients with CRC showed association with increased nonpolyposis CRC risk of disruptive variants in RPS20, IL12RB1, POLE2, MRE11 and POT1, and of FAN1 c.149T>G (p.Met50Arg). Lack of association was demonstrated for LIMK2, PTPN12, LRP6, PTPRJ, POLQ, BLM, MCM9 and FOCAD variants. Additional studies are required to provide conclusive evidence for SEMA4A, WIF1, HNRNPA0 c.-110G>C, and FOCAD large deletions.
Keywords: cancer genetics; cancer predisposition; early-onset colorectal cancer; familial colorectal cancer; germline mutation; hereditary cancer.
© 2020 Wiley Periodicals LLC.
Similar articles
-
Dominantly Inherited Hereditary Nonpolyposis Colorectal Cancer Not Caused by MMR Genes.J Clin Med. 2020 Jun 23;9(6):1954. doi: 10.3390/jcm9061954. J Clin Med. 2020. PMID: 32585810 Free PMC article. Review.
-
Germline variation in O6-methylguanine-DNA methyltransferase (MGMT) as cause of hereditary colorectal cancer.Cancer Lett. 2019 Apr 10;447:86-92. doi: 10.1016/j.canlet.2019.01.019. Epub 2019 Jan 21. Cancer Lett. 2019. PMID: 30677446
-
PTPRJ haplotypes and colorectal cancer risk.Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2782-5. doi: 10.1158/1055-9965.EPI-08-0513. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18843023
-
Identification of Novel Candidate Genes for Early-Onset Colorectal Cancer Susceptibility.PLoS Genet. 2016 Feb 22;12(2):e1005880. doi: 10.1371/journal.pgen.1005880. eCollection 2016 Feb. PLoS Genet. 2016. PMID: 26901136 Free PMC article.
-
Update on genetic predisposition to colorectal cancer and polyposis.Mol Aspects Med. 2019 Oct;69:10-26. doi: 10.1016/j.mam.2019.03.001. Epub 2019 Mar 18. Mol Aspects Med. 2019. PMID: 30862463 Review.
Cited by
-
Two novel qualitative transcriptional signatures robustly applicable to non-research-oriented colorectal cancer samples with low-quality RNA.J Cell Mol Med. 2021 Apr;25(7):3622-3633. doi: 10.1111/jcmm.16467. Epub 2021 Mar 14. J Cell Mol Med. 2021. PMID: 33719152 Free PMC article.
-
Dose-dependent reduction of somatic expansions but not Htt aggregates by di-valent siRNA-mediated silencing of MSH3 in HdhQ111 mice.Sci Rep. 2024 Jan 24;14(1):2061. doi: 10.1038/s41598-024-52667-3. Sci Rep. 2024. PMID: 38267530 Free PMC article.
-
POLE2 silencing inhibits the progression of colorectal carcinoma cells via wnt signaling axis.Cancer Biol Ther. 2024 Dec 31;25(1):2392339. doi: 10.1080/15384047.2024.2392339. Epub 2024 Aug 18. Cancer Biol Ther. 2024. PMID: 39155507 Free PMC article.
-
Potential miRNA biomarkers and therapeutic targets for early atherosclerotic lesions.Sci Rep. 2023 Mar 1;13(1):3467. doi: 10.1038/s41598-023-29074-1. Sci Rep. 2023. PMID: 36859458 Free PMC article.
-
Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome.Int J Clin Oncol. 2024 Jul;29(7):953-963. doi: 10.1007/s10147-024-02518-y. Epub 2024 Apr 14. Int J Clin Oncol. 2024. PMID: 38615286 Free PMC article.
References
REFERENCES
-
- AlDubayan, S. H., Giannakis, M., Moore, N. D., Han, G. C., Reardon, B., Hamada, T., … Van Allen, E. M. (2018). Inherited DNA-repair defects in colorectal cancer. American Journal of Human Genetics, 102(3), 401-414. https://doi.org/10.1016/j.ajhg.2018.01.018
-
- Azuara, D., Rodriguez-Moranta, F., de Oca, J., Soriano-Izquierdo, A., Mora, J., Guardiola, J., … Capella, G. (2010). Novel methylation panel for the early detection of colorectal tumors in stool DNA. Clinical Colorectal Cancer, 9(3), 168-176. https://doi.org/10.3816/CCC.2010.n.023
-
- Bainbridge, M. N., Armstrong, G. N., Gramatges, M. M., Bertuch, A. A., Jhangiani, S. N., Doddapaneni, H., … Bondy, M. L. (2015). Germline mutations in shelterin complex genes are associated with familial glioma. Journal of the National Cancer Institute, 107(1), 384. https://doi.org/10.1093/jnci/dju384
-
- Belhadj, S., Moutinho, C., Mur, P., Setien, F., Llinas-Arias, P., Perez-Salvia, M., … Valle, L. (2019). Germline variation in O(6)-methylguanine-DNA methyltransferase (MGMT) as cause of hereditary colorectal cancer. Cancer Letters, 447, 86-92. https://doi.org/10.1016/j.canlet.2019.01.019
-
- Brockschmidt, A., Trost, D., Peterziel, H., Zimmermann, K., Ehrler, M., Grassmann, H., … Weber, R. G. (2012). KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas. Brain, 135(Pt 4), 1027-1041. https://doi.org/10.1093/brain/aws045
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous